We are live on
!
Find out more
ProShares Ultra Health Care
Fund managers haven’t disclosed any holdings of RXL yet.
RXL Hedge Fund Activity: Q1 2026 in Review
17 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in ProShares Ultra Health Care (RXL) for Q1 2026, worth a combined $6.23M — up 49% from $4.17M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new RXL positions and 3 closed out — a net gain of 1 holder — while 5 added to existing stakes and 2 trimmed.
The largest buyer was IMC Chicago, opening a new position worth an estimated $3.46M. The largest seller was Osaic Holdings, cutting an estimated $676K.
- 17 institutional investors held ProShares Ultra Health Care (RXL) as of Q1 2026, up from 16 in Q4 2025.
- Funds reported $6.23M of ProShares Ultra Health Care stock for Q1 2026, up 49% quarter-over-quarter.
- 4 funds opened new ProShares Ultra Health Care positions in Q1 2026 and 3 closed out, a net change of +1 holder.
- The largest ProShares Ultra Health Care buyer in Q1 2026 was IMC Chicago, an estimated $3.46M added.
- The largest ProShares Ultra Health Care seller in Q1 2026 was Osaic Holdings, an estimated $676K sold.
Based on aggregated 13F filings for Q1 2026.